Docket Management
Docket: 02N-0007 - Agency Info Collection Activities; CGMP Regulations for Finished Pharmaceuticals
Comment Number: EC -2

Accepted - Volume 1

Comment Record
Commentor Mr. dong jiang Date/Time 2002-03-07 00:47:04
Organization xiamen kingdomway vitamin incorporation
Category Food Industry

Comments for FDA General
Questions
1. Is the proposed collection of information necessary for the proper performance of FDA's functions? Will the information have practical utility? test
2. What is the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used? test
3. What are ways to enhance the quality, utility, and clarity of the information to be collected? a
4. What are ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology? a
5. General Comments a




EC -2